Oramed Pharmaceuticals, Inc. (ORMP)
4.13
+0.01
(+0.24%)
USD |
NASDAQ |
Oct 23, 16:00
4.14
+0.01
(+0.24%)
After-Hours: 20:00
Oramed Pharmaceuticals Price to Book Value : 0.5375 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.5375 |
| October 22, 2026 | 0.5362 |
| October 21, 2026 | 0.5388 |
| October 20, 2026 | 0.5401 |
| October 19, 2026 | 0.5283 |
| October 16, 2026 | 0.5296 |
| October 15, 2026 | 0.544 |
| October 14, 2026 | 0.5388 |
| October 13, 2026 | 0.5427 |
| October 12, 2026 | 0.5557 |
| October 09, 2026 | 0.5635 |
| October 08, 2026 | 0.5466 |
| October 07, 2026 | 0.5687 |
| October 06, 2026 | 0.57 |
| October 05, 2026 | 0.5921 |
| October 02, 2026 | 0.5843 |
| October 01, 2026 | 0.583 |
| September 30, 2026 | 0.6077 |
| September 29, 2026 | 0.6103 |
| September 28, 2026 | 0.6181 |
| September 25, 2026 | 0.6155 |
| September 24, 2026 | 0.6233 |
| September 23, 2026 | 0.6142 |
| September 22, 2026 | 0.6181 |
| September 21, 2026 | 0.6116 |
| Date | Value |
|---|---|
| September 18, 2026 | 0.6168 |
| September 17, 2026 | 0.6077 |
| September 16, 2026 | 0.6012 |
| September 15, 2026 | 0.6012 |
| September 14, 2026 | 0.6077 |
| September 11, 2026 | 0.6064 |
| September 10, 2026 | 0.6194 |
| September 09, 2026 | 0.622 |
| September 08, 2026 | 0.6481 |
| September 04, 2026 | 0.652 |
| September 03, 2026 | 0.6416 |
| September 02, 2026 | 0.6598 |
| September 01, 2026 | 0.6312 |
| August 31, 2026 | 0.6533 |
| August 28, 2026 | 0.6546 |
| August 27, 2026 | 0.6637 |
| August 26, 2026 | 0.6949 |
| August 25, 2026 | 0.678 |
| August 24, 2026 | 0.6272 |
| August 21, 2026 | 0.6259 |
| August 20, 2026 | 0.6233 |
| August 19, 2026 | 0.6233 |
| August 18, 2026 | 0.622 |
| August 17, 2026 | 0.5947 |
| August 14, 2026 | 0.583 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.793 |
| Corcept Therapeutics, Inc. | 13.13 |
| Veru, Inc. | 1.346 |
| Johnson & Johnson | 7.789 |
| Eli Lilly & Co. | 35.39 |
Price to Book Value Related Metrics
| PE Ratio | 1.005 |
| Price | 4.13 |
| Earnings Yield | 99.53% |
| Market Cap | 170.63M |
| Normalized PE Ratio | 3.940 |